50
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients

, , , , , & show all
Pages 3169-3175 | Published online: 27 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Aneta Cymbaluk-Płoska, Anita Chudecka-Głaz, Anna Jagodzińska, Ewa Pius-Sadowska, Agnieszka Sompolska-Rzechuła, Bogusław Machaliński & Janusz Menkiszak. (2018) Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer. OncoTargets and Therapy 11, pages 1363-1372.
Read now

Articles from other publishers (13)

Woo Yeon Hwang, Dong Hoon Suh, Kidong Kim, Yong Beom Kim & Jae Hong No. (2022) Serum Human Epididymis Protein 4 as a Prognostic Marker in Cervical Cancer. Cancer Control 29, pages 107327482210977.
Crossref
Rebecca Karkia, Sarah Wali, Annette Payne, Emmanouil Karteris & Jayanta Chatterjee. (2022) Diagnostic Accuracy of Liquid Biomarkers for the Non-Invasive Diagnosis of Endometrial Cancer: A Systematic Review and Meta-Analysis. Cancers 14:19, pages 4666.
Crossref
Li‐na Han, Yi‐wei Han & Ping Yan. (2022) Prognostic values of human epididymis protein 4 expression in patients with endometrial cancer: A systematic review and meta‐analysis. Journal of Obstetrics and Gynaecology Research 48:9, pages 2255-2269.
Crossref
Hayam Fathy Mohammad, Nashwa El-Khazragy, S. Hassan, Fatma Abukra, Rehab M. Abdelrahman, Amr Ahmed Mahmoud Riad & Mohamed A. Abdelhafeez. (2022) HE4 is a Beneficial Biomarker in Endometrial Adenocarcinoma. Current Women s Health Reviews 18:2.
Crossref
Roya Behrouzi, Chloe E. Barr & Emma J. Crosbie. (2021) HE4 as a Biomarker for Endometrial Cancer. Cancers 13:19, pages 4764.
Crossref
Manon Degez, Hélène Caillon, Anne Chauviré-Drouard, Maxime Leroy, David Lair, Norbert Winer, Thibault Thubert & Vincent Dochez. (2021) Endometrial cancer: A systematic review of HE4, REM and REM-B. Clinica Chimica Acta 515, pages 27-36.
Crossref
Aneta Cymbaluk-Płoska, Paula Gargulińska, Michał Bulsa, Sebastian Kwiatkowski, Anita Chudecka-Głaz & Kaja Michalczyk. (2021) Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?. Diagnostics 11:4, pages 626.
Crossref
Kaja Michalczyk & Aneta Cymbaluk-Płoska. (2020) The Role of Zinc and Copper in Gynecological Malignancies. Nutrients 12:12, pages 3732.
Crossref
Shi-Yuan Liu, Muhammad Ahsan Bilal, Jian-Hong Zhu & Shao-Min Li. (2020) Diagnostic value of serum human epididymis protein 4 in esophageal squamous cell carcinoma. World Journal of Gastrointestinal Oncology 12:10, pages 1167-1176.
Crossref
Ying He, Jing Wang, Chun-Xing Ma & Yan-Hua Kang. (2020) Role of Human Epididymis Protein 4 (HE4) in Determining Survival of Patients With Endometrial Cancer: A Meta-Analysis. Technology in Cancer Research & Treatment 19, pages 153303382097166.
Crossref
Chang Liu, Ying Li, Shasha Hu, Yao Chen, Li Gao, Dajiang Liu, Hongtao Guo & Yongxiu Yang. (2018) Clinical significance of matrix metalloproteinase-2 in endometrial cancer. Medicine 97:29, pages e10994.
Crossref
Li-man Li, Yu-xuan Zhu, Yi Zhong, Tao Su, Xiao-ming Fan, Qian Xi, Ming-yong Li, Jun Fu, Hong Tan & Shan Liu. (2018) Human epididymis protein 4 in endometrial cancer: A meta-analysis. Clinica Chimica Acta 482, pages 215-223.
Crossref
Yunpeng Shi, Chang Su, Haixia Hu, He Yan, Wei Li, Guohui Chen, Dahai Xu, Xiaohong Du & Ping Zhang. (2018) Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma. PLOS ONE 13:6, pages e0198896.
Crossref